Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för finafloxacin. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

9 träffar

Bibliografisk träff 2014-08-19

Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria.

Genzel GH, Stubbings W, Stîngu CS, Labischinski H, Schaumann R.

Int J Antimicrob Agents · journal article · DOI 10.1016/j.ijantimicag.2014.07.006

Bibliografisk träff 2011-09-21

Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes.

Idelevich EA, Kriegeskorte A, Stubbings W, Kahl BC, Peters G, Becker K.

J Antimicrob Chemother · research support, non-u.s. gov't; journal article · DOI 10.1093/jac/dkr393

Bibliografisk träff 2011-06-27

Human pharmacokinetics and safety profile of finafloxacin, a new fluoroquinolone antibiotic, in healthy volunteers.

Patel H, Andresen A, Vente A, Heilmann HD, Stubbings W, Seiberling M, Lopez-Lazaro L, Pokorny R, Labischinski H.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1128/aac.00832-10

Bibliografisk träff 2011-06-27

In vitro spectrum of activity of finafloxacin, a novel, pH-activated fluoroquinolone, under standard and acidic conditions.

Stubbings W, Leow P, Yong GC, Goh F, Körber-Irrgang B, Kresken M, Endermann R, Labischinski H.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00833-10

Bibliografisk träff 2011-05-18

Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila.

Lemaire S, Van Bambeke F, Tulkens PM.

Int J Antimicrob Agents · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijantimicag.2011.03.002

Bibliografisk träff 2011-02-28

Urinary pharmacokinetics and bactericidal activity of finafloxacin (200 and 800 mg) in healthy volunteers receiving a single oral dose.

Wagenlehner FM, Wagenlehner CM, Blenk B, Blenk H, Schubert S, Dalhoff A, Naber KG.

Chemotherapy · research support, non-u.s. gov't; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1159/000321028

Bibliografisk träff 2011-01-18

Comparative in vitro activities of the novel antibacterial finafloxacin against selected Gram-positive and Gram-negative bacteria tested in Mueller-Hinton broth and synthetic urine.

Dalhoff A, Stubbings W, Schubert S.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00886-10

Bibliografisk träff 2010-10-12

Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance.

Emrich NC, Heisig A, Stubbings W, Labischinski H, Heisig P.

J Antimicrob Chemother · research support, non-u.s. gov't; journal article · DOI 10.1093/jac/dkq375

Bibliografisk träff 2010-01-25

Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin-sensitive and -resistant Acinetobacter baumannii isolates.

Higgins PG, Stubbings W, Wisplinghoff H, Seifert H.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.01637-09